Delivery Order SPE2DX22D0010-SPE2D826FBM10
- Not listed
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $12,642.22 for Nucynta Tabs 75mg, a pain management pharmaceutical, by the Defense Logistics Agency's Medical Supply Chain on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Nucynta Tabs 50mg valued at $4,442.48 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain on October 23, 2025. The contract is non-competitive, non-set-aside, and represents a single delivery order with an ultimate completion date of October 24, 2025. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp received a delivery order award for Nucynta Tabs 75mg, a pain management pharmaceutical, valued at $12,160.31 with a firm fixed price structure. The contract was competitively awarded without a set-aside designation and will be completed by November 18, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal procurement entity, with the place of performance at AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,230.11 for Nucynta Tabs 100mg on August 21, 2025. This firm fixed-price contract, which has no set-aside designation, was funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the awardee's Conshohocken facility, with an ultimate completion date of August 22, 2025. The delivery order represents a short-duration...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 25, 2025, for the supply of Nucynta ER Tablets 100mg with a ceiling value of $12,560.28. The competitively awarded, firm fixed-price delivery order is funded by the Defense Department's Medical Supply Chain and is due for completion by November 26, 2025. This award represents a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Nucynta Tabs 75mg, a pain management pharmaceutical. This firm fixed-price delivery order, valued at $7,937.42, was competitively awarded without set-aside designation and is scheduled for completion by December 10, 2025. The awardee will perform work at its corporate office in Conshohocken, Pennsylvania, leveraging its established position as a major...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 8, 2025, for 60 tablets of Nucynta ER 200 mg. This firm fixed-price, competitively awarded contract carries a ceiling value of $2,411.52 and is scheduled for completion by September 9, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,279.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nucynta 100 mg tablets (100-count units) on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a non-set-aside, competitively awarded contract with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,789.57 for 100 tablets of Nucynta 75 mg on September 2, 2025, with completion targeted for September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical procurement...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBM10Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,558.60 for Nucynta Tabs 100mg on December 3, 2025, with an ultimate completion date of December 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is funded through the Department of Defense Medical Supply Chain. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime IDV encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and the U.S. Coast Guard. The company's federal contract portfolio demonstrates its established capability to meet Department of Defense pharmaceutical procurement requirements through competitive award processes across diverse product categories and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 12/2/25 |